Thank you This live web event has ended. Thank you for attending. Contributors Shashi Amur, Ph.D. Shashi Amur is an expert in the area of disease biomarkers, biomarkers in drug development and pharmacogenomics. Dr. Amur received her Ph.D. in Biochemistry from the Indian Institute of Science, India and completed a post-doctoral fellowship in Neuroscience at Temple University and at the University of California at Los Angeles. She then joined Specialty Laboratories in Santa Monica, CA as a Molecular Biologist. Following this, Dr. Amur was a Senior Scientist at Applied Biosystems and gained expertise in the application of DNA sequencing and PCR technologies. In 2005, Dr. Amur joined FDA as a Senior Genomics Reviewer in the Office of Clinical Pharmacology (OCP). She served as the Scientific Lead in the Biomarker Qualification Program from 2012-2017 for the Office of Translational Sciences (OTS). She is currently a Scientific Advisor in OTS, CDER, FDA. Prior to joining FDA, she was the Associate Director of Assay Development at Neotropix, Inc. and Immune Tolerance Network.